Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Iron Level and Myelin Content in the Ventral Striatum Predict Memory Performance in the Aging Brain.
Cytokines and Disability in Interferon-β-1b Treated and Untreated Women with Multiple Sclerosis.
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial.
Rehabilitation in transverse myelitis.
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis.
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden.
Agreement between physician's recommendation and fitness-to-drive decision in multiple sclerosis.
Alemtuzumab (Lemtrada) - NICE says yes in final draft guidance
PLEGRIDY™ (peginterferon beta-1a) approved in the European Union for the treatment of multiple sclerosis
Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
Direct angiotensin AT2-receptor stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
Is it time for a new global classification of multiple sclerosis?
Laquinimod Halted MS Disability But Not Relapses
European medicines agency's committee for medicinal products for human use issues positive opinion on marketing authorisation application for Fampyra
Deep 3D Convolutional Encoder Networks with Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation.
A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for Multiple Sclerosis: The MusiQoL-MCAT.
Human neural precursor cells promote neurologic recovery in a viral model of multiple sclerosis.
Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report.
Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Substance Name: Dronabinol
MiR-126: a novel route for natalizumab action?
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.
mfERG_LAB: Software for processing multifocal electroretinography signals.
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.

Pages